https://onlinelibrary.wiley.com/doi/full/10.1002/cti2.1081
Retracted: Dual targeting of RANKL and PD‐1 with a bispecific ...
Sep 27, 2019 ... 30 Specifically, the RMP1-14 (anti-PD-1 antibody) sequence was engineered as a 'CrossMabCH1-CL', in which the CH1 and CL sequences were ...